SRZN Surrozen Inc. Company Total Asset Base

SRZN (Surrozen Inc) - company brandmark

Surrozen, Inc. (SRZN) is relying on the commercial launch of regenerative therapies, where the primary driver will be the sale of gut and liver restoration agents. The company's intellectual capital is based on stem cell patents that create value for years to come. Current total assets amount to 109.15. The market price trend reflects the development dynamics of a molecule portfolio that is currently in the clinical testing stage.

Surrozen Corp (SRZN) - Company Total Assets from 07/04/2022 to 10/30/2026

Financial and market metric breakdowns for Surrozen Corp (SRZN)

- stock quotes and analyst forecast:
Share Price surrozen.com|SRZN - Price Target Chart
- market capitalization data:
Market Capitalization Surrozen Inc.|SRZN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Price of a Share Surrozen|SRZN - Book Capitalization|Market-to-Book Ratio surrozen.com|SRZN - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Surrozen, Inc.|SRZN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Surrozen Inc.|SRZN - Company Aggregate Debts|Debts to Book Value Surrozen Inc.|SRZN - Company Long-Term Debt|Company Short-Term Debt Surrozen|Quick Liquidity surrozen.com
- earnings and valuation multiples indicators:
SRZN - Company Net Income
Fundamental valuation:SRZN surrozen.com
Core merchandise of Surrozen, Inc.

This indicator reflects the total value of Surrozen, Inc. (SRZN) resources, reverse-calculated via return on assets (ROA) to determine the actual scale of asset control. The total asset dynamics on the GURU.Markets platform allow for an assessment of the Surrozen, Inc. (SRZN) base capitalization, where resource growth directly correlates with the potential to create a monopoly tissue regeneration technology and future pricing power within the biotech sector.

Main competitors

Total Business Assets MESO|Aggregate Company Assets Lineage Cell Therapeutics, Inc.|Cryo-Cell International Inc (CCEL) - Company Total Asset Base|Cumulative Company Assets FBLG (FibroBiologics, Inc.)|Aggregate Business Assets LGVN|Company Total Assets BRTX (BioRestorative Therapies, Inc.)|Creative Medical Technology Holdings, Inc. (CELZ) - Company Assets